Analytical characteristics of high-sensitivity cardiac troponin assays.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Clinical Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1373/clinchem.2011.165795PMID 21965555
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of population selection on the 99th percentile reference value for cardiac troponin assays.

  2012cited by this paper
• Biological variation and reference change value of high-sensitivity troponin T in healthy individuals during short and intermediate follow-up periods.

  2011cited by this paper
• A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study.

  2011cited by this paper
• Utility of Absolute and Relative Changes in Cardiac Troponin Concentrations in the Early Diagnosis of Acute Myocardial Infarction

  2011cited by this paper
• Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis?

  2011cited by this paper
• Multicenter analytical evaluation of a high-sensitivity troponin T assay.

  2011cited by this paper
• Clinical performance of a new point-of-care cardiac troponin I assay compared to three laboratory troponin assays.

  2011cited by this paper
• Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T.

  2011cited by this paper
• Defining the serum 99th percentile in a normal reference population measured by a high-sensitivity cardiac troponin I assay.

  2010cited by this paper
• Biological and analytical variability of a novel high-sensitivity cardiac troponin T assay.

  2010cited by this paper
• High-sensitivity cardiac troponin: hype, help, and reality.

  2010cited by this paper
• Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population.

  2010cited by this paper
• Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults.

  2010cited by this paper
• Analytical validation of a high-sensitivity cardiac troponin T assay.

  2010cited by this paper
• Standardisation of cardiac troponin I measurement: past and present

  2010cited by this paper
• Sensitive troponin I assay in early diagnosis of acute myocardial infarction

  2010cited by this paper
• Assay imprecision and 99th-percentile reference value of a high-sensitivity cardiac troponin I assay.

  2009cited by this paper
• Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia.

  2009cited by this paper
• Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events.

  2009cited by this paper
• Early diagnosis of myocardial infarction with sensitive cardiac troponin assays.

  2009cited by this paper
• Short- and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice.

  2009cited by this paper
• Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study.

  2009cited by this paper
• A new season for cardiac troponin assays: it's time to keep a scorecard.

  2009cited by this paper
• Comparison of emergency department patient classification by point-of-care and central laboratory methods for cardiac troponin I.

  2008cited by this paper
• Rapid risk stratification in suspected acute coronary syndrome using serial multiple cardiac biomarkers: A pilot study

  2008cited by this paper
• Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction

  2008cited by this paper
• A rapid point-of-care cardiac marker testing strategy facilitates the rapid diagnosis and management of chest pain patients in the emergency department.

  2008cited by this paper
• Multiple molecular forms of circulating cardiac troponin: analytical and clinical significance

  2008cited by this paper
• National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biomarkers of heart failure.

  2008cited by this paper
• Universal definition of myocardial infarction.

  2007cited by this paper
• National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes.

  2007cited by this paper
• Serum and plasma cardiac troponin I 99th percentile reference values for 3 2nd-generation assays.

  2007cited by this paper
• National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes.

  2007cited by this paper
• Universal definition of myocardial infarction.

  2007cited by this paper
• Elevations in cardiac troponin measurements: False false-positives

  2007cited by this paper
• Size-exclusion chromatography of circulating cardiac troponin T.

  2006cited by this paper
• Influence of imprecision on ROC curve analysis for cardiac markers.

  2006cited by this paper
• Point-of-care i-STAT cardiac troponin I for assessment of patients with symptoms suggestive of acute coronary syndrome.

  2006cited by this paper
• Negative interference in cardiac troponin I immunoassays by circulating troponin autoantibodies.

  2005cited by this paper
• Validation of the 99th percentile cutoff independent of assay imprecision (CV) for cardiac troponin monitoring for ruling out myocardial infarction.

  2005cited by this paper
• Point-of-care testing reduces length of stay in emergency department chest pain patients.

  2005cited by this paper
• Evaluation of imprecision for cardiac troponin assays at low-range concentrations.

  2004cited by this paper
• Stratus CS cardiac troponin I method: performance characteristics including imprecision at low concentrations.

  2004cited by this paper
• The STARD Statement for Reporting Studies of Diagnostic Accuracy: Explanation and Elaboration

  2003cited by this paper
• European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials.

  2002cited by this paper
• The Erlanger chest pain evaluation protocol: a one-year experience with serial 12-lead ECG monitoring, two-hour delta serum marker measurements, and selective nuclear stress testing to identify and exclude acute coronary syndromes.

  2002cited by this paper
• Ninety-minute accelerated critical pathway for chest pain evaluation.

  2001cited by this paper
• Ninety-Minute Exclusion of Acute Myocardial Infarction By Use of Quantitative Point-of-Care Testing of Myoglobin and Troponin I

  2001cited by this paper
• Evaluation of a Rapid Bedside Immunochromatographic Assay for Detection of Cardiac Troponin I in Whole Blood

  2001cited by this paper
• Standardization of cardiac troponin I assays: round Robin of ten candidate reference materials.

  2001cited by this paper
• Rapid measurement of cardiac markers on Stratus CS.

  2000cited by this paper
• Comparison of cardiac troponin I measurements on whole blood and plasma on the Stratus CS analyzer and comparison with AxSYM.

  2000cited by this paper
• Use of recombinant human cardiac Troponin T for standardization of third generation Troponin T methods.

  1999cited by this paper
• Biochemical Factors Influencing Measurement of Cardiac Troponin I in Serum

  1999cited by this paper
• Degradation of cardiac troponin I: implication for reliable immunodetection.

  1998cited by this paper
• Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization.

  1998cited by this paper
• Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim.

  1998cited by this paper
• Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex.

  1997influential reference
• Human and canine cardiac troponin T and creatine kinase-MB distribution in normal and diseased myocardium. Infarct sizing using serum profiles.

  1995cited by this paper
• Cardiac Troponin I A Marker With High Specificity for Cardiac Injury

  1993cited by this paper
• Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction.

  1991cited by this paper
• Cardiac-specific troponin-I radioimmunoassay in the diagnosis of acute myocardial infarction.

  1987cited by this paper

• Considerations and pragmatic strategies for implementation of point of care testing for high sensitivity cardiac troponin into the acute care setting

  2026cites this paper
• Therapeutic Potential of Myrica esculenta Fruit Extract in Attenuating Myocardial Damage in an Isoproterenol-Induced Experimental Model of Myocardial Infarction in Mice

  2026cites this paper
• Cardiac Troponin Thresholds in Children and Young Adults: A Multi-Center Cohort Study.

  2026cites this paper
• Measurement Integrity in Modern Clinical Practice: Bringing Precision to Everyday Decision-Making.

  2026cites this paper
• Periprocedural Myocardial Infarction: Do We Need an Updated Definition?

  2026cites this paper
• Cardiac Troponins and Cardiovascular Disease Risk Prediction: An Individual-Participant-Data Meta-Analysis.

  2025cites this paper
• High-Sensitivity Troponin Zones: An Alternative Approach to Clinical Decisions.

  2025cites this paper
• Two Point‐of‐Care Cardiac Troponin I Immunoassays Have Acceptable Analytical Performance for the Detection of Measurands of Cardiac Troponin I Cardiac Muscle Homogenates From Southern‐Central Black Rhinoceros ( Diceros bicornis minor ) and Southern White Rhinoceros ( Ceratotherium simum simum )

  2025cites this paper
• Clinical Reflections on the Impact of High‐Sensitivity Troponin I Assay Changes on Emergency Department Diagnosis and Disposition

  2025cites this paper
• Performance evaluation of a new high-sensitivity cardiac troponin T assay: hs-cTnT (CLIA) assay

  2025cites this paper
• Effect of change of high‐sensitivity troponin I assay on emergency department diagnosis and disposition of patients with possible acute coronary syndrome

  2025cites this paper
• High-sensitivity cardiac troponin I and risk of dementia: the 25-year longitudinal Whitehall II study

  2025cites this paper
• Rapid diagnosis of different cardiovascular disease events from early released cardiac biomarkers, cTnI, BNP, and CRP, by biosensor technology

  2025cites this paper
• High-sensitivity point-of-care measurement of cardiac troponin.

  2025cites this paper
• Cardiac troponin at the point of care in acute and chronic coronary syndromes

  2025cites this paper
• Cardiac Troponin

  2025cites this paper
• Assessment of PTAH and Troponin-I in Detecting Early Myocardial Infarction Postmortem

  2025cites this paper
• Accelerated diagnostic pathways for myocardial infarction using a Siemens High-Sensitivity cardiac troponin I assay.

  2025cites this paper
• The Role of High-Sensitivity Cardiac Troponin and Ischemia-Modified Albumin in Patients with Lower Extremity Peripheral Arterial Disease

  2025cites this paper
• Disrupting the Status Quo: Reimagining How We Use Troponin for Diagnosing Myocardial Infarction.

  2025cites this paper
• Inflammatory Profile and Risk of Post-Intervention Infection in Relation to Myocardial Necrosis Markers

  2025cites this paper
• Aptamer-Based Planar Electric Double-Layer Field-Effect Transistor: A Novel Approach for Sensitive Troponin I Sensing

  2025cites this paper
• Advances in Acute Myocardial Infarction (AMI) Diagnostics: Classical Biomarkers, Emerging Tools, and the Rise of Non-Invasive Sampling

  2025cites this paper
• Subclinical Myocardial Injury and Global Cognitive Performance

  2025cites this paper
• Interpretable Prediction of Myocardial Infarction Using Explainable Boosting Machines: A Biomarker-Based Machine Learning Approach

  2025cites this paper
• Defining Chronic Myocyte Injury With hs-cTnT

  2025cites this paper
• Quantification of Myocardial Biomarkers in Sudden Cardiac Deaths Using a Rapid Immunofluorescence Method for Simultaneous Biomarker Analysis

  2025cites this paper
• Review of Literature and Recommended Procedures for Management of Unusual Cases of False Positive Troponin Tests

  2025cites this paper
• Prognostic utility of high-sensitivity troponins according to atherosclerotic vascular disease severity.

  2025cites this paper
• High sensitivity troponin-I and myocardial injury after noncardiac surgery for cancer in a large prospective cohort

  2025cites this paper
• Chest Pain With Significantly Elevated Troponins: Be Wary of False Positives

  2025cites this paper
• Early prediction of orthodontic gingival enlargement using S100A4: a biomarker-based risk stratification model.

  2025cites this paper
• Anthracycline-induced cardiomyopathy: risk prediction, prevention and treatment

  2025cites this paper
• Diabetes, Subclinical Myocardial Injury or Stress and Risk of Heart Failure Subtypes: The Jackson Heart Study.

  2025cites this paper
• Health Care Resource Utilization for Patients With Suspected Myocardial Infarction

  2025cites this paper
• Impact of subthreshold troponin levels and temporal trends on short term adverse cardiovascular outcomes in patients discharged from the emergency department: a RACE-IT trial substudy.

  2025cites this paper
• Pharmacologic agents for perioperative cardioprotection in noncardiac surgery.

  2025cites this paper
• High Sensitivity Cardiac Troponin T Versus Cardiac Troponin I on Prediction of Significant Coronary Artery Disease in Patients Hospitalized Due to Symptomatic Atrial Fibrillation

  2025cites this paper
• La troponine en pratique, mais au fait à quoi ça sert ?

  2025cites this paper
• Earlier Diagnosis the Myocardial Infarction of Older Patients by Troponin Test

  2024cites this paper
• High-sensitivity cardiac troponin I-guided combination angiotensin receptor blockade and beta blocker therapy to prevent anthracycline cardiotoxicity: the Cardiac CARE RCT

  2024cites this paper
• Cardiac Troponins I and T as Biomarkers of Cardiomyocyte Injury—Advantages and Disadvantages of Each

  2024cites this paper
• The value of troponin measurement in carotid revascularization: are we making the most of it?

  2024cites this paper
• Metabolic dysfunction and incidence of heart failure subtypes among Black individuals: The Jackson Heart Study

  2024cites this paper
• Role of Antitroponin Antibodies and Macrotroponin in the Clinical Interpretation of Cardiac Troponin

  2024cites this paper
• Evaluating the Commutability of Reference Materials for α-Fetoprotein: Accurate Value Assignment With Multiple Systems and Trueness Verification

  2024cites this paper
• Rapid Acute Coronary Syndrome Evaluation Over One Hour With High-Sensitivity Cardiac Troponin I: A United States-Based Stepped-Wedge, Randomized Trial.

  2024cites this paper
• Evaluation of Age and Sex Differences in Contemporary versus High-Sensitivity Troponin I Measurement in Hospitalized Patients

  2024cites this paper
• High-Sensitivity Troponin: Finding a Meaningful Delta

  2024influential citation
• Clinical relevance and advances in detection of translational biomarker cardiac troponin.

  2024cites this paper
• Clinical Biochemistry of Serum Troponin

  2024cites this paper
• A Single High-Sensitivity Cardiac Troponin T Strategy for Ruling Out Myocardial Infarction

  2024cites this paper
• Establishment of high-sensitivity cardiac troponin I reference interval for a hospitalized paediatric population under improved selection criteria in the Shandong area

  2024cites this paper
• Pathophysiological mechanisms underlying increased circulating cardiac troponin in noncardiac surgery: a narrative review.

  2024cites this paper
• Cardiac troponin I as predictor for cardiac and other mortality in the German randomized lung cancer screening trial (LUSI)

  2024influential citation
• Long-term prognosis of low high-sensitivity cardiac troponin T in the emergency department compared with the general population

  2024cites this paper
• A Biomarker-Based Diagnostic Model for Cardiac Dysfunction in Childhood Cancer Survivors

  2024cites this paper
• The Correlation of Serum Adropin with Cardiovascular Risk Factors in the Experimental Rat Model of Chronic Kidney Disease and Its Implication in the Ameliorative Effect of Angiotensin-Converting Enzyme Inhibitors

  2024cites this paper
• Current Evidence for the Use of High-Sensitivity Troponin Assays in the Emergency Department

  2024cites this paper
• Point-of-care high-sensitivity cardiac troponin in suspected acute myocardial infarction assessed at baseline and 2 h.

  2024cites this paper
• Exercise-Induced Troponin Elevation in High-Performance Cross-Country Skiers

  2024cites this paper
• Importance of H-FABP in Early Diagnosis of Acute Myocardial Infarction

  2024cites this paper
• Biotin interference with laboratory test results

  2024cites this paper
• Biomarkers of Importance in Monitoring Heart Condition After Acute Myocardial Infarction

  2024cites this paper
• High-sensitivity cardiac troponin I and risk of dementia: 25-year longitudinal study in the Whitehall II cohort

  2024cites this paper
• Use of Cardiac Troponin Assays in Hemodialysis Patients

  2024cites this paper
• Defensive Medicine in an Emergency Department: The Overuse of High-Sensitivity Cardiac Troponin I Testing

  2024cites this paper
• Systolic Blood Pressure, Diastolic Blood Pressure and Pulse Pressure and the Risk of Subclinical Myocardial Injury: The HUNT Study

  2024cites this paper
• Proposed framework regarding management of patients with breast cancer and anti-cancer treatment-related elevation in cardiac troponin

  2024cites this paper
• Chest Pain at Rest With Unremarkable ECG and Cardiac Enzymes: Case Study Emphasising the Importance of Clinical Suspicion in the Diagnosis of Coronary Artery Disease

  2024cites this paper
• High-Sensitive Cardiospecific Troponins: The Role of Gender-Specific Concentration in the Diagnosis of Acute Coronary Syndrome (Descriptive Review)

  2023cites this paper
• Suspected myocardial infarction in the emergency department: An evaluation of clinical thresholds for the Beckman Coulter Access hsTnI high‐sensitivity cardiac troponin I assay

  2023cites this paper
• Troponin in early presenters to rule out myocardial infarction

  2023cites this paper
• High-sensitive cardiospecific troponins: the role of sex-specific concentration in the diagnosis of acute coronary syndrome (mini-review).

  2023cites this paper
• The clinical importance of high-sensitivity cardiac troponin measurements for risk prediction in non-cardiac surgery

  2023cites this paper
• Incidence and risk factors of postoperative acute myocardial injury in noncardiac patients: A systematic review and meta-analysis

  2023cites this paper
• Frequency, compliance, and yield of cardiac testing after high-sensitivity troponin accelerated diagnostic protocol implementation.

  2023cites this paper
• Defining Myocardial Infarction in trials of people receiving hemodialysis: consensus report from the SONG-HD MI Expert Working group.

  2023cites this paper
• The Bilateral Remote Ischaemic Conditioning in Children (BRICC) trial: a two-centre, double-blind, randomised controlled trial in young children undergoing cardiac surgery

  2023cites this paper
• Cardiac Troponin I in Patients Undergoing Percutaneous and Surgical Myocardial Revascularization: Comparison of Analytical Methods

  2023cites this paper
• Comparison of high‐sensitive cardiac troponin T and I in patients with chronic coronary syndrome

  2023cites this paper
• Modern View on the Role of Sex-Specific Levels of High-Sensitive Cardiospecific Troponins T and I in the Diagnosis of Myocardial Infarction

  2023cites this paper
• Persistent Elevation of Troponin I in a Pediatric Patient Resulting From Macrotroponin Complex.

  2023cites this paper
• Achieving Equity in Emergency Medicine Quality Measures Requires a Sex and Gender Lens.

  2023cites this paper
• High sensitivity troponin-I threshold to predict perioperative myocardial infarction

  2023cites this paper
• Validation of a 0/1 h Algorithm for Rapid Diagnosis of Myocardial Infarction Using a High-Sensitivity Troponin I Assay.

  2023cites this paper
• Gender Specificities of Cardiac Troponin Serum Levels: From Formation Mechanisms to the Diagnostic Role in Case of Acute Coronary Syndrome

  2023cites this paper
• Advances in rapid diagnostic tests for myocardial infarction patients

  2023cites this paper
• Optimizing the Clinical Use of High-Sensitivity Troponin Assays: A Review

  2023cites this paper
• Sex and race differences in the performance of the European Society of Cardiology 0/1‐h algorithm with high‐sensitivity troponin T

  2023cites this paper
• Cardiac troponin release in athletes: what do we know and where should we go?

  2023cites this paper
• In Vitro Study of the Effect of Vanillin Derivatives on Aryl Esterase, Troponine and Lipid Profile in Atherosclerosis Patients as Compared to Normal Subjects

  2023cites this paper
• An Alternating Current Electroosmotic Flow‐Based Ultrasensitive Electrochemiluminescence Microfluidic System for Ultrafast Monitoring, Detection of Proteins/miRNAs in Unprocessed Samples

  2023cites this paper
• High-Sensitivity Troponin I and Cardiovascular Events in Stable Coronary Artery Disease: Insights from a Longitudinal Outpatient Study

  2023cites this paper
• Cardioprotective and Antifibrotic Effects of Low-Dose Renin–Angiotensin–Aldosterone System Inhibitors in Type 1 Diabetic Rat Model

  2023cites this paper
• The Role of HEART Score in Predicting Major Adverse Cardiac Events in Patients with Possible Acute Coronary Syndrome Presenting to the Emergency Department

  2023cites this paper
• Cardiac Troponin I but Not N-Terminal Pro-B-Type Natriuretic Peptide Predicts Outcomes in Cardiogenic Shock

  2023cites this paper
• Comparison of heart, grace and TIMI scores to predict major adverse cardiac events from chest pain in a Spanish health care region

  2023cites this paper
• Analytical assays and bootstrap resampling method to validate performance of the Roche Elecsys STAT highly sensitive troponin T assay and its application for the ‘rule-out’ part of ESC guidelines for NTSTEMI

  2023cites this paper
• Association between troponin level and medium-term mortality in 20 000 hospital patients

  2023cites this paper